Cost–utility of nelarabine for the first‐line treatment of newly diagnosed pediatric T‐cell acute lymphoblastic leukemia in Canada.

Autor: Shoukry, Roaa, Moskalewicz, Alexandra, Bradley, Nicole, Bond, Elizabeth, Sala, Mandy, Gupta, Sumit, Gibson, Paul, Pechlivanoglou, Petros
Zdroj: Pediatric Blood & Cancer; Jan2025, Vol. 72 Issue 1, p1-8, 8p
Databáze: Complementary Index
Externí odkaz: